학술논문
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
Document Type
Artikel
Author
Ostergaard, M; van Vollenhoven, RF; Rudin, A; Hetland, ML; Heiberg, MS; Nordstrom, DC; Nurmohamed, MT; Gudbjornsson, B; Ornbjerg, LM; Boyesen, P; Lend, K; Horslev-Petersen, K; Uhlig, T; Sokka, T; Grondal, G; Krabbe, S; Lindqvist, J; Gjertsson, I; Glinatsi, D; Kapetanovic, MC; Aga, AB; Faustini, F; Parmanne, P; Lorenzen, T; Giovanni, C; Back, J; Hendricks, O; Vedder, D; Rannio, T; Grenholm, E; Ljosa, MK; Brodin, E; Lindegaard, H; Soderbergh, A; Rizk, M; Kastbom, A; Larsson, P; Uhrenholt, L; Just, SA; Stevens, DJ; Laurbjerg, TB; Bakland, G; Olsen, IC; Haavardsholm, EA; Lampa, J
Source
Annals of the rheumatic diseases. 82(10):1286-1295
Subject
Language
English
English
English
ISSN
1468-2060